Rhabdomyolysis-related renal tubular damage studied by proton nuclear magnetic resonance spectroscopy of urine.
Bairaktari
Eleni
E
Laboratory of Biochemistry, University Hospital, University of Ioannina, Medical School, 455 00 Ioannina, Greece. ebairakt@cc.uoi.gr
Seferiadis
Konstantin
K
Liamis
George
G
Psihogios
Nikolaos
N
Tsolas
Orestes
O
Elisaf
Moses
M
D015415:Biomarkers / Q000652:urine; D004359:Drug Therapy, Combination; D015248:Gemfibrozil / Q000627:therapeutic use; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications / Q000188:drug therapy; D007674:Kidney Diseases / Q000209:etiology / Q000503:physiopathology / Q000652:urine*; D007684:Kidney Tubules / Q000503:physiopathology*; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D008562:Membrane Glycoproteins / Q000652:urine; D011725:Pyridines / Q000627:therapeutic use; D012206:Rhabdomyolysis / Q000150:complications*; D014360:Trypsin Inhibitor, Kunitz Soybean; D001613:beta 2-Microglobulin / Q000652:urine
D015415:Biomarkers; D008562:Membrane Glycoproteins; D011725:Pyridines; C109148:SPINT2 protein, human; D001613:beta 2-Microglobulin; D014360:Trypsin Inhibitor, Kunitz Soybean; C086276:cerivastatin; D015248:Gemfibrozil